Top Pharma Competitive Intelligence Professionals Gather at Pharma CI Asia Conference & Exhibition

Press Release ( - TSIM SHA TSUI, Hong Kong - Apr 20, 2016 - The value of competitive intelligence to marketing and the rapid growth of Asian medical tourism will be just some of the critical issues discussed at the 2016 Pharma CI Asia Conference & Exhibition. The event, which has set a new standard for CI discussion in Asia, will take place 14-15 June at the Kowloon Shangri-La Hotel in Hong Kong.

Competitive intelligence has never been more essential to a company’s survival and increased globalization means the competition has never been more fierce. That’s why companies need the resources and strategies to expand their scope beyond the borders of local markets. This conference brings together the top thought leaders who understand the relationship between regional industries – like here in Asia – and the global marketplace.

These CI experts from the world’s most influential companies will present a program that offers new methodologies into how intelligence should be gathered and, more importantly, how this intelligence should be used. These insights will help boost innovation and help intelligence professionals stay ahead in this rapidly changing industry.

Other topics up for discussion include:

·         From Policy to Evidence: the Strategy of Evidence-Based Market Access in China Healthcare Market

·         Who Says MNC’s Cannot Innovate New Business Models?

·         How to Adapt Optimal Market Access Strategies for Big Pharma Considering Local Dynamic Regulation Evolvement in China

·         Competitive Intelligence as a Driver for External Innovation in R&D Context

·         And Many More Topics!

For the last decade and going strong today, the Pharma CI Conference & Exhibition is the best and largest assembly of pharmaceutical competitive intelligence executives in the world!

The Pharma CI Conference features the participation of the world’s top companies, including: Abbott Laboratories, Astellas, AstraZeneca, Bristol Myers Squibb, Deallus Consulting, Eisai, GE Healthcare, Harvest Moon Pharmaceuticals, L.E.K. Consulting, Lifescience Dynamics, Medtronic, MSD (Merck Sharp & Dohme), Novartis, PharmaForce International, Sanofi China, Shionogi & Co., Takeda, The Hong Kong Association of the Pharmaceutical Industry (HKAPI), UCB, Versatis, Inc., Xinbang Pharmaceuticals and many more.

To register to attend the conference, go to:

To view the detailed agenda, go to:

For more information, call +1-212-228-7974 or email

Source : Pharma CI Conference & Exhibition



Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login


If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/ services/ business mentioned and hereby disclaims any content contained in this press release.